Recent advances in understanding and managing resistant/refractory hypertension

Michael Doumas; Konstantinos Imprialos; Manolis S. Kallistratos; Athanasios J. Manolis

doi:https://doi.org/10.12688/f1000research.21669.1

doi.org/10.12688/f1000research.21669.1

Recent advances in understanding and managing resistant/refractory hypertension

Michael Doumas

38

,

Konstantinos Imprialos

15

,

..., Athanasios J. Manolis

38

F1000Research

Volume: 9, Pages: 169 - 169

Published: Mar 9, 2020

Abstract

The management of resistant hypertension presents several challenges in everyday clinical practice. During the past few years, several studies have been performed to identify efficient and safe pharmacological and non-pharmacological options for the management of such patients. The Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2) trial demonstrated...

Paper Fields

Paper Details

Title

Recent advances in understanding and managing resistant/refractory hypertension

DOI

doi.org/10.12688/f1000research.21669.1

Published Date

Mar 9, 2020

Journal

F1000Research

Volume

9

Pages

169 - 169

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History